Press Releases

and/or
565 News Releases found
Pictured: Craig Moskowitz
Positive Data from Pivotal Phase III Study Could Improve Standard of Care for Hodgkin Lymphoma Patients

In a late-stage clinical trial, Hodgkin lymphoma patients who received brentuximab vedotin post-transplant lived longer without disease progression than patients who received only supportive care.
Studies Led by Memorial Sloan Kettering Investigators Show Immunotherapy Drugs Improve Outcomes in Hodgkin Lymphoma Patients

A number of scientific breakthroughs have led to the development of drugs that unleash the power of the immune system to recognize and attack cancer. For Classical Hodgkin lymphoma patients, two phase I studies are already demonstrating dramatic results.
Pictured: Jedd Wolchok, Alexandra Snyder Charen, and Timothy Chan
Memorial Sloan Kettering Team Makes Key Discovery in Understanding Immunotherapy’s Successes—And Its Failures

A collaborative team of leaders in the field of cancer immunology has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do not.
MSK West Harrison
Memorial Sloan Kettering Brings Cancer Care Closer to Home for Hudson Valley Residents

Memorial Sloan Kettering’s suburban presence is expanding with its newest and largest state-of-the-art facility set to welcome patients on October 6 in West Harrison, New York.
New Academic-Industry Partnership Creates Online Registry for Patients Tested for Inherited Cancer Risk

The Prospective Registry Of Multi-Plex Testing (PROMPT) - a new online, volunteer registry for individuals who have been tested for inherited mutations in cancer-causing genes - will provide data vital to improving our understanding of newly discovered, cancer-associated genes and allow current and future generations to better interpret and benefit from knowledge of their genomes.
Hartford HealthCare Cancer Institute Officially Certified as the First Member of the Memorial Sloan Kettering Cancer Alliance

The Hartford HealthCare Cancer Institute has been formally certified as the charter member of the Memorial Sloan Kettering Cancer Alliance, a transformative initiative to improve the quality of care and outcomes for cancer patients in community healthcare settings.
Pictured: Yu Chen
The Newest Precision Medicine Tool: Prostate Cancer Organoids

Research led by investigators at Memorial Sloan Kettering has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory.
MSK and Pereira & O’Dell New York Launch Campaign to Announce MSK’s New Creative Platform: More Science. Less Fear.

MSK introduced its first new creative campaign in nearly two decades. The creative platform and campaign elements were developed and produced by MSK’s creative agency of record, Pereira & O’Dell New York.
Richard J. O’Reilly
Media Advisory
Transplantation Shown to Be Highly Effective in Treating Immune Deficiency in Children

Babies who are born with severe combined immunodeficiency can be successfully treated with a transplant of blood-forming stem cells, according to experts led by Memorial Sloan Kettering’s Richard O’Reilly.
Media Advisory
Memorial Sloan Kettering Ranks First in the Nation for Cancer Care

Memorial Sloan Kettering Cancer Center is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals.